Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. STKE, 20 September 2005
Vol. 2005, Issue 302, p. pe46
[DOI: 10.1126/stke.stke.3022005pe46]

PERSPECTIVES

Potassium Channels as Targets for Therapeutic Intervention

Maria L. Garcia* and Gregory J. Kaczorowski

Department of Ion Channels, Merck Research Laboratories, Post Office Box 2000, Rahway, NJ 07065, USA.

Abstract: The potassium channel superfamily presents a rich source of targets for therapeutic intervention. Indeed, the development of specific potassium channel modulators could lead to the effective treatment of various diseases for which current therapies are clearly suboptimal. Numerous factors play a role in determining whether the successful clinical development of such drugs can ever be achieved. However, the large body of information accumulated over the last few years on the structure and function of potassium channels is expected to drive drug-development efforts in the pharmaceutical industry on these targets, with the ultimate goal of developing therapies that will improve patient quality of life.

*Corresponding author. E-mail: maria_garcia{at}merck.com

Citation: M. L. Garcia, G. J. Kaczorowski, Potassium Channels as Targets for Therapeutic Intervention. Sci. STKE 2005, pe46 (2005).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Ion Channels as Drug Targets: The Next GPCRs.
G. J. Kaczorowski, O. B. McManus, B. T. Priest, and M. L. Garcia (2008)
J. Gen. Physiol. 131, 399-405
   Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882